Full dedication and expertise for your projects
At DiabInnov, we are committed to excellence and high value in all our customer-oriented services.
The treatment of diabetes and metabolic alterations requires a comprehensive understanding of these diseases, the study of the underlying pathophysiological mechanisms and the identification of potential biomarkers and therapeutic targets.
DiabInnov provides its customers with the expertise to probe mechanisms underlying islet failure and pathology in multiple forms of diabetes, with the goal of finding new approaches for treatment and prevention of this disease.
Our experienced team of scientists accompany you from the early steps of proof of concept to the preclinical and clinical studies. The concerted work between DiabInnov and its customers enables the design of experimental protocols appropriate to meet your objectives and the identification of the most suitable experimental models.